Control of Prostate Cancer Using Organotin Polymers

Cancer statistics, 2011

Rebecca L. Siegel, Elizabeth Ward, Otis W. Brawley et al. · CA A Cancer Journal for Clinicians · 2011 · 4.1K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

P. Vasey, Stan B. Kaye, Rachel Morrison et al. · PubMed · 1999 · 691 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

PC3 is a cell line characteristic of prostatic small cell carcinoma

Sheng Tai, Yin Sun, Jill Squires et al. · The Prostate · 2011 · 488 citations

Medicine, Endocrinology, Oncology +17

Organotin polymers as anticancer and antiviral agents

Charles E. Carraher, Michael R. Roner · Journal of Organometallic Chemistry · 2013 · 125 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers

Elvire Fournier, Catherine Passirani, Nathalie Colin et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2003 · 78 citations

Pharmacy, Biomedical Engineering, Oncology +14